http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6045809-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b300468d6a83d79386897a1b05b5128b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1996-01-12^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-04-04^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aef9cdeeb58d9d90ac2879ad7b1311e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7368258314b3eacd88d365658696f496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1be79c566065f1ae28825b79ffc8a468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ae59f5615fddde8e008d78493a3bc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ff92875e82bc5809af8aed1012f023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33273e21301ecb7fb0b1287a036a244
publicationDate 2000-04-04^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6045809-A
titleOfInvention Pharmaceutical compositions containing a superoxide dismutase
abstract PCT No. PCT/FR95/00055 Sec. 371 Date Sep. 12, 1997 Sec. 102(e) Date Sep. 12, 1997 PCT Filed Jan. 12, 1996 PCT Pub. No. WO96/21462 PCT Pub. Date Jul. 18, 1996Novel pharmaceutical compositions that are particularly suitable for oral administration of superoxide dismutases (SODs) and that have good bioavailability and therapeutic efficacy. These compositions are made up of a combination of a superoxide dismutase and at least one lipids or proteins. The lipids are exemplified by ceramides, and the proteins are exemplified by prolamines or polymer films based on such prolamines. A pharmaceutically acceptable vehicle can also be included in the composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7150870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6503506-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03013438-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006116452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014225496-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669068-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007099151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8092794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6335388-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004105851-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006257493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008119386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012038512-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009202509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006239987-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9254308-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2433640-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009226409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03013438-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410048-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005232996-A1
priorityDate 1995-01-12^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5271961-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019400-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0292964-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0342620-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54488686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129741568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127348321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129119613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135926033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135836815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129645792

Showing number of triples: 1 to 85 of 85.